Cardiology

Redefining heart disease risk, prevention and management

Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the journal Circulation.

Alzheimer's disease & dementia

FDA OKs marketing of new test to help diagnose Alzheimer's disease

The U.S. Food and Drug Administration granted marketing approval for the Lumipulse G β-Amyloid Ratio (1-42/1-40) test, the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer disease, ...

Diabetes

Could drugs for type 2 diabetes help those with type 1?

Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...

page 34 from 40